Serotonin receptors are critical molecular targets within the central nervous system that regulate mood, cognition, sleep, and numerous physiological processes. These receptors, divided into seven major families (5-HT1 to 5-HT7), influence neural communication, emotional balance, and behavioral regulation.

The Serotonin Receptors session explores receptor diversity, signal transduction pathways, and pharmacological implications across psychiatric and neurological conditions. Researchers discuss receptor subtype selectivity and its role in developing effective treatments for depression, anxiety, schizophrenia, and migraine.

At the Serotonin Receptors Conference, neuroscientists, pharmacologists, and clinicians present molecular, genetic, and therapeutic findings shaping our understanding of serotonin’s function. The session highlights receptor interactions with dopaminergic and glutamatergic systems, alongside the role of serotonin in neurodevelopment and plasticity.

This session is ideal for experts in neuropharmacology, psychopharmacology, and molecular neuroscience. Attendees will explore the translation of receptor-level discoveries into clinical interventions that restore emotional and cognitive health.

Recent research in Neuropsychopharmacology reveals how serotonin receptor signaling contributes to neuroadaptive changes underlying antidepressant response, supporting the development of selective agonists and allosteric modulators for improved therapeutic precision.